Mitchell Rubinstein, MD has been appointed Chief Medical Officer for Palms of Pasadena Hospital and St. Petersburg General Hospital. He is the newest member of the senior management teams for both hospitals. Dr. Rubinstein is already experienced in this role, having served as Vice President of Medical Affairs at The Valley Hospital in New Jersey.

Prior to accepting this position, Dr. Rubinstein served as Physician Advisor for University Hospital, Newark New Jersey. His extensive experience also includes serving as a consultant for Joint Commission Resources as well as The Mediware Corporation. In addition he was a member of the Scientific Advisory Committee for the Xenex Corporation.

He earned his medical degree at The University of Texas Health Science Center in San Antonio, Texas. He completed a general surgery internship, residency and fellowship at New York Medical College, a cardiothoracic surgery residency at Montefiore Hospital and Medical Center and a cardiothoracic surgery fellowship at Newark Beth Israel Medical Center. Dr. Rubinstein is board certified by the American Board of Thoracic Surgery. He was in active practice as a cardiac surgeon at The Valley Hospital, and also served as the Medical Director for their Cardiac Surgical ICU. Dr. Rubinstein has a BA in Psychobiology from New York University, Washington Square and University College of Arts and Science, and an MBA from The University of Massachusetts, Eisenberg School of Management Center.

As the HCA South Pinellas Market CMO, Dr. Rubinstein will work collaboratively with respective hospital medical staffs and administrative leadership teams to champion local and West Florida Division HCA enterprise-wide quality initiatives.

Dr. Rubinstein is available for interviews. For more information contact Judy Goetz by phone at (727) 341-7545 or by email

“I am proud to join organizations that deliver high quality, personalized care to every patient.” said Chief Medical Officer Mitchell Rubinstein. “I look forward to helping these hospitals build upon their superior quality outcomes and patient safety initiatives.”